Other News To Note
Friday, September 9, 2011
Probiodrug AG, of Halle, Germany, published data providing key insights into the onset and development of Alzheimer's disease (AD) in the Journal of Neuroscience. The research described the generation and characterization of a novel animal model that solely expresses N-truncated human amyloid-β (Aβ), which in turn is modified by the so-called QC enzyme (glutaminyl cyclase) to pyroglutamate residue Aβ.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.